Advances in treatment of pulmonary arterial hypertension: patent review.

about

A Novel Therapeutic Approach in the Treatment of Pulmonary Arterial Hypertension: Allium ursinum Liophylisate Alleviates Symptoms Comparably to Sildenafil.

P2860

Q36414291-4D00D4FE-3D0C-40F1-ADAA-B766EEA9B73F

P2860

Advances in treatment of pulmonary arterial hypertension: patent review.

Item

http://www.wikidata.org/entity/Q39206788

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Advances in treatment of pulmonary arterial hypertension: patent review.

@en

Advances in treatment of pulmonary arterial hypertension: patent review.

@nl

type

Item

label

Advances in treatment of pulmonary arterial hypertension: patent review.

@en

Advances in treatment of pulmonary arterial hypertension: patent review.

@nl

prefLabel

Advances in treatment of pulmonary arterial hypertension: patent review.

@en

Advances in treatment of pulmonary arterial hypertension: patent review.

@nl

P1476

Advances in treatment of pulmonary arterial hypertension: patent review.

@en

P2093

Bhuvaneshwar Vaidya

http://www.w3.org/2001/XMLSchema#string

Christine Marie Cunningham

http://www.w3.org/2001/XMLSchema#string

Jeanette C Perron

http://www.w3.org/2001/XMLSchema#string

Mansoureh Eghbali

http://www.w3.org/2001/XMLSchema#string

Matthew Pangallo

http://www.w3.org/2001/XMLSchema#string

Srikanth Kolluru

http://www.w3.org/2001/XMLSchema#string

P2860

Apelin-APJ signaling: a potential therapeutic target for pulmonary arterial hypertension

Dichloroacetate prevents and reverses pulmonary hypertension by inducing pulmonary artery smooth muscle cell apoptosis.

Inflammation and immunity in the pathogenesis of pulmonary arterial hypertension

Reversal of experimental pulmonary hypertension by PDGF inhibition.

PDGF signaling in pulmonary arterial hypertension.

Nuclear factor κB inhibition reduces lung vascular lumen obliteration in severe pulmonary hypertension in rats.

An endothelial apelin-FGF link mediated by miR-424 and miR-503 is disrupted in pulmonary arterial hypertension

Definitions and diagnosis of pulmonary hypertension.

2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS):

Role for miR-204 in human pulmonary arterial hypertension

P304

907-918

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/13543776.2017.1313232

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Grégoire Ruffenach

Vivek Gupta

P577

2017-03-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28355094

http://www.w3.org/2001/XMLSchema#string

Advances in treatment of pulmonary arterial hypertension: patent review.

about

P2860

P2860

Advances in treatment of pulmonary arterial hypertension: patent review.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698